The FDA has unveiled fresh measures aimed at tackling persistent worries surrounding the improper use, abuse, addiction, and overdose of prescription stimulants prescribed for ADHD treatment. TwitteRx
The US Food and Drug Administration has announced new action to address ongoing concerns about misuse, abuse,, and overdose of prescription stimulants used to treat attention-deficit/hyperactivity disorder .
"The current prescribing information for some prescription stimulants does not provide up to date warnings about the harms of misuse and abuse, and particularly that most individuals who misuse prescription stimulants get their drugs from other family members or peers,"Going forward, updated drug labels will clearly state that patients should never share their prescription stimulants with anyone, and the boxed warning will describe the risks of misuse, abuse, addiction, and overdose...
The boxed warning will also advise heathcare professionals to monitor patients closely for signs and symptoms of misuse, abuse, and addiction.The FDA encourages prescribers to assess patient risk of misuse, abuse, and addiction before prescribing aA recent literature review by the FDA found that friends and family members are the most common source of prescription stimulant misuse and abuse . Estimates of such use range from 56% to 80%.
Misuse/abuse of a patient's own prescription make up 10% to 20% of people who report nonmedical stimulant use.The groups at highest risk for misuse/abuse of prescription stimulants are young adults aged 18 to 25 years, college students, and adolescents and young adults who have been diagnosed with
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Personal Hygiene Tips for ADHD Brains (and Bodies)Self-care routines are boring. Try these personal hygiene and grooming hacks for greater efficiency and less shame for adults and adolescents with ADHD.
Les mer »
Hormonal Changes & ADHD: A Lifelong Tug-of-WarAs estrogen and testosterone levels rise and fall through each stage of life, ADHD symptoms swing with them, according to new ADDitude research on hormonal changes.
Les mer »
FDA approves new type of drug to treat menopausal hot flashesThe FDA has approved a once-a-day pill that neurologically targets the body's temperature control center, which can calm menopausal hot flashes.
Les mer »
FDA blocks marketing on 6,500 flavored e-cigarette productsThe FDA blocked 10 companies from marketing or distributing 6,500 flavored e-liquid and e-cigarette products, part of its campaign against tobacco products being marketed to youths. The agency said that retailers who sell them risk an enforcement action.
Les mer »
New menopause drug for hot flashes gets FDA approvalU.S. health regulators on Friday approved a new type of drug for women dealing with uncomfortable hot flashes caused by menopause.
Les mer »